Impax Pharmaceuticals launches treatment for Parkinson's disease Researchers are developing inhalable vaccines targeting lung-specific diseases Walgreens Flu Index: Flu continues to rage across the South Keryx Biopharmaceuticals begins shipping treatment for patients with chronic kidney disease on dialysis CDC: ILI rates reach 5.9% FDA approves Saxenda from Novo Nordisk Actavis, Adamas approved for Namzaric FDA approves sBLA for Genentech's Gazyva GSK shareholders approve Novartis deal Teva's QNasl approved for pediatric allergic rhinitis First Previous 146 147 148 149 150 Next Last